We're here for you and your family at Arkansas Children's – and at home. Tell us more about yourself for a personalized experience.
Our comprehensive pediatric cardiac program is home to state-of-the-art technologies, world-class cardiologists and innovative procedures. This unmatched combination of resources makes us the region’s leading provider of comprehensive cardiovascular care for our most important patient: your child.
Arkansas Children’s announced today the Children’s Miracle Network Hospitals fundraising campaign with Walmart and Sam’s Club raised more than $1 million.
The Translational Research Center at the Arkansas Children’s Research Institute receives $11.5 million to use “Big Data” to discover new therapies.
Arkansas Children's Hospital Becomes Nation's First Therapeutic Site in Launch of Groundbreaking Clinical Trial for Pediatric Acute Leukemia
A Phase 2/3 Safety, Pharmacokinetics, and efficacy study of Nirmatrelvir/Ritonavir in pediatric, non-hospitalized symptomatic participants with COVID-19 who are at risk of progression to severe disease.
The purpose of this study is to observe and study the growth velocity, body proportionality, and complications (comorbidities) in children with achondroplasia.
A prospective open label, multicenter study to evaluate the feasibility and side effects of using molecularly guided therapy in combination with standard therapy followed by a Randomized Controlled Trial of standard immunotherapy with or without DFMO followed by DFMO maintenance for Subjects with Newly Diagnosed High-Risk Neuroblastoma.
We know times like these are difficult, especially for children. School is an enormous part of your kids’ lives. It’s a place where they learn, grow, and mature. When an unthinkable tragedy like Uvalde happens, Arkansas Children’s wants you prepared with resources to meet your children's needs right where they are.
We know that healthcare can be complicated, so we make it as easy as possible to access primary and specialty care.